CP
Cantabio Pharmaceuticals Inc. Stock: price and insider trades · United States
Cantabio Pharmaceuticals Inc.: what insiders have been doing
We have very little insider data for Cantabio Pharmaceuticals Inc. so far: the most recent filing dates from 11 October 2018. With so few records, no pattern can be drawn yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2014FY ended March 2014 · cache
Income statement
Net income-1.8M
Last declaration on 11 October 2018
Declarations5 total
- 2,400,000 sharesCommon StockSEC:0001648371-18-000001:2
- 3,600,000 sharesCommon StockSEC:0001648371-18-000001:3
- 7,352,941 sharesCommon StockSEC:0001648371-18-000001:4
- 13,500,000 sharesCommon StockSEC:0001648371-18-000001:0
- 10,079,147 sharesCommon StockSEC:0001648371-18-000001:1
5 of 5 declarations
About Cantabio Pharmaceuticals Inc.
Cantabio Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative diseases. It emphasizes biology-based approaches to enhance the quality of life for patients.
